154 related articles for article (PubMed ID: 21127151)
1. Computational methods are significant determinants of the associations and definitions of insulin resistance using the homeostasis model assessment in women of reproductive age.
Safar FH; Mojiminiyi OA; Al-Rumaih HM; Diejomaoh MF
Clin Chem; 2011 Feb; 57(2):279-85. PubMed ID: 21127151
[TBL] [Abstract][Full Text] [Related]
2. Effect of homeostasis model assessment computational method on the definition and associations of insulin resistance.
Mojiminiyi OA; Abdella NA
Clin Chem Lab Med; 2010 Nov; 48(11):1629-34. PubMed ID: 20704534
[TBL] [Abstract][Full Text] [Related]
3. Cut-off points of homeostasis model assessment of insulin resistance, beta-cell function, and fasting serum insulin to identify future type 2 diabetes: Tehran Lipid and Glucose Study.
Ghasemi A; Tohidi M; Derakhshan A; Hasheminia M; Azizi F; Hadaegh F
Acta Diabetol; 2015 Oct; 52(5):905-15. PubMed ID: 25794879
[TBL] [Abstract][Full Text] [Related]
4. Serum pigment epithelium-derived factor is elevated in women with polycystic ovary syndrome and correlates with insulin resistance.
Yang S; Li Q; Zhong L; Song Y; Tian B; Cheng Q; Qing H; Xia W; Luo M; Mei M
J Clin Endocrinol Metab; 2011 Mar; 96(3):831-6. PubMed ID: 21209034
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].
Roa Barrios M; Arata-Bellabarba G; Valeri L; Velázquez-Maldonado E
Endocrinol Nutr; 2009 Feb; 56(2):59-65. PubMed ID: 19627713
[TBL] [Abstract][Full Text] [Related]
6. L:A ratio, Insulin resistance and metabolic risk in women with polycystic ovarian syndrome.
Gupta V; Mishra S; Mishra S; Gupta V
Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S697-S701. PubMed ID: 28529126
[TBL] [Abstract][Full Text] [Related]
7. TriGlycerides and high-density lipoprotein cholesterol ratio compared with homeostasis model assessment insulin resistance indexes in screening for metabolic syndrome in the chinese obese children: a cross section study.
Liang J; Fu J; Jiang Y; Dong G; Wang X; Wu W
BMC Pediatr; 2015 Sep; 15():138. PubMed ID: 26416207
[TBL] [Abstract][Full Text] [Related]
8. Hypoadiponectinemia: a useful marker of dyslipidemia in women with polycystic ovary syndrome.
Chang CY; Chen MJ; Yang WS; Yeh CY; Ho HN; Chen SU; Yang YS
Taiwan J Obstet Gynecol; 2012 Dec; 51(4):583-90. PubMed ID: 23276562
[TBL] [Abstract][Full Text] [Related]
9. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
Singh S; Akhtar N; Ahmad J
Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540
[TBL] [Abstract][Full Text] [Related]
10. HOMA1-IR and HOMA2-IR indexes in identifying insulin resistance and metabolic syndrome: Brazilian Metabolic Syndrome Study (BRAMS).
Geloneze B; Vasques AC; Stabe CF; Pareja JC; Rosado LE; Queiroz EC; Tambascia MA;
Arq Bras Endocrinol Metabol; 2009 Mar; 53(2):281-7. PubMed ID: 19466221
[TBL] [Abstract][Full Text] [Related]
11. The HOMA-Adiponectin (HOMA-AD) Closely Mirrors the HOMA-IR Index in the Screening of Insulin Resistance in the Brazilian Metabolic Syndrome Study (BRAMS).
Vilela BS; Vasques AC; Cassani RS; Forti AC; Pareja JC; Tambascia MA; ; Geloneze B
PLoS One; 2016; 11(8):e0158751. PubMed ID: 27490249
[TBL] [Abstract][Full Text] [Related]
12. Triglycerides to High-Density Lipoprotein Cholesterol Ratio Can Predict Impaired Glucose Tolerance in Young Women with Polycystic Ovary Syndrome.
Song do K; Lee H; Sung YA; Oh JY
Yonsei Med J; 2016 Nov; 57(6):1404-11. PubMed ID: 27593868
[TBL] [Abstract][Full Text] [Related]
13. Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome.
Morrison SA; Goss AM; Azziz R; Raju DA; Gower BA
Hum Reprod; 2017 Jan; 32(1):185-192. PubMed ID: 27827322
[TBL] [Abstract][Full Text] [Related]
14. High-molecular-weight adiponectin is inversely associated with sympathetic activity in polycystic ovary syndrome.
Shorakae S; Abell SK; Hiam DS; Lambert EA; Eikelis N; Jona E; Sari CI; Stepto NK; Lambert GW; de Courten B; Teede HJ
Fertil Steril; 2018 Mar; 109(3):532-539. PubMed ID: 29428305
[TBL] [Abstract][Full Text] [Related]
15. Fasting plasma glucose is a stronger predictor of diabetes than triglyceride-glucose index, triglycerides/high-density lipoprotein cholesterol, and homeostasis model assessment of insulin resistance: Tehran Lipid and Glucose Study.
Tohidi M; Baghbani-Oskouei A; Ahanchi NS; Azizi F; Hadaegh F
Acta Diabetol; 2018 Oct; 55(10):1067-1074. PubMed ID: 30066042
[TBL] [Abstract][Full Text] [Related]
16. Low plasma atrial natriuretic peptide: a new piece in the puzzle of polycystic ovary syndrome.
Lauria PB; Del Puerto HL; Reis AM; Candido AL; Reis FM
J Clin Endocrinol Metab; 2013 Dec; 98(12):4882-9. PubMed ID: 24057296
[TBL] [Abstract][Full Text] [Related]
17. Association between circulating adiponectin levels and polycystic ovarian syndrome.
Mirza SS; Shafique K; Shaikh AR; Khan NA; Anwar Qureshi M
J Ovarian Res; 2014 Feb; 7():18. PubMed ID: 24502610
[TBL] [Abstract][Full Text] [Related]
18. Insulin resistance according to β-cell function in women with polycystic ovary syndrome and normal glucose tolerance.
Song DK; Hong YS; Sung YA; Lee H
PLoS One; 2017; 12(5):e0178120. PubMed ID: 28542421
[TBL] [Abstract][Full Text] [Related]
19. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
Ardawi MS; Rouzi AA
Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640
[TBL] [Abstract][Full Text] [Related]
20. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
Pehlivanov B; Mitkov M
Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
